Hélène Blons

Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples.

Qun Zhong, Pierre Laurent-Puig, Valerie Taly, 2013, Clinical chemistry.

p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos.

Jessica Zucman-Rossi, Alexis Descatha, Pierre Laurent-Puig, 2010, Lung cancer.

Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction.

Alain Bel, Philippe Menasché, Jérôme Larghero, 2018, Journal of the American College of Cardiology.

Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer

Pierre Laurent-Puig, Françoise Le Pimpec-Barthes, Diane Damotte, 2015, Oncotarget.

Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study

Franck Morin, Patrick Merle, Pascal Auquier, 2018, European Respiratory Journal.

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Jean Mosser, Franck Morin, Gérard Zalcman, 2016, The Lancet.

DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma

Pierre Laurent-Puig, Cristina Lecchi, Aurélie Cazes, 2012, Tumor Biology.

Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations

Karla Perez-Toralla, Valérie Taly, Pierre Laurent-Puig, 2016, PloS one.

Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis

Bruno Landi, Thierry Lecomte, Pierre Laurent-Puig, 2002, International journal of cancer.